DoD CDMRP funding and prostate cancer research for FY 2012

It appears that research funding of $80 million will again be directed for use to study prostate cancer through the Department of Defense’s Congressionally Directed Medical Research Program (DoD CDMRP) for the financial year 2012. This is a big and important “win” for prostate cancer research during a time of fiscal constraint.

It’s time to badger Congress — yet again, pretty please!

Many readers will already have seen the report we posted about Senator McCain’s desire to eliminate the Prostate Cancer Research Program within the Congressionally Directed Medical Research Program (CDMRP) — one of the most successful prostate cancer research initiatives. Now you can work with the rest of the advocacy community to counter this.

48 hours at the IMPaCT symposium in Orlando: Part III

So the question any smart prostate cancer patient should ask himself — especially if he has any degree of good scientific education — is, “How do I get myself invited to the next IMPaCT meeting?”

48 hours at the IMPaCT symposium in Orlando: Part I

Most medical-scientific meetings that deal (at least in part) with prostate cancer are inhabited by academic scientists, clinicians, and various types of representative of commercial companies.

Senator McCain wants to cut funding for prostate cancer research by $80 million

Senator John McCain is a man who has been treated successfully not once, not twice, but three times for malignant melanoma.

House to hold CDMRP hearing, including prostate cancer testimony

The Appropriations Defense subcommittee of the U.S. House of Representatives is to convene a hearing tomorrow (May 20, 2010), featuring public testimony regarding prostate cancer research within the Congressionally Directed Medical Research Program (CDMRP).

Follow

Get every new post delivered to your Inbox.

Join 268 other followers